ANZ share price edges up as Suncorp job-cut row flares; CPI and RBA meeting loom
22 January 2026
2 mins read

ANZ share price edges up as Suncorp job-cut row flares; CPI and RBA meeting loom

Sydney, Jan 22, 2026, 17:49 AEDT — Market closed

  • ANZ shares ended 0.6% higher following a union’s sharp criticism of planned job cuts at Suncorp Bank
  • Banks powered a rebound on the ASX, boosted by a robust jobs report that raised expectations for further rate hikes
  • Traders are focusing on the inflation data due January 28 and the RBA meeting set for February 2–3

ANZ Group Holdings Limited (ANZ.AX) shares finished Thursday 0.6% higher at A$36.40, moving alongside gains in the wider banking sector despite mounting union backlash against planned layoffs at Suncorp Bank. 1

The S&P/ASX 200 closed up 0.8% at 8,849 points, boosted by gains in financial stocks after jobs data sparked fresh speculation about a rate hike in February. “The creation of more than 65,000 new jobs last month shows a much stronger labour market than any of us anticipated,” said KPMG chief economist Brendan Rynne. 2

For ANZ, the rate debate intersects with a more tangled, company-specific issue. The Suncorp integration was expected to be disruptive; now, job cuts have pushed it into political territory.

The Finance Sector Union reported that 197 roles at Suncorp Bank are affected, with 66 expected job losses, mainly in Brisbane. The union has urged the federal government to step in. FSU national president Wendy Streets said ANZ claims to be meeting its obligations, but the union “has not seen the evidence to support that claim.” ANZ, for its part, says it remains “firmly committed” to its promises, including no net job cuts in Australia directly tied to the acquisition. 3

ANZ wasn’t the only one on the rise. Westpac Banking Corp gained roughly 2%, and National Australia Bank jumped about 3%, reflecting a shift by investors toward rate-sensitive banks. 4

The labour report revealed the seasonally adjusted unemployment rate dropped to 4.1% in December. Employment increased by 65,000, driven mainly by a 55,000 gain in full-time positions. 5

Money markets quickly priced in about a 50% chance of a 25 basis-point hike at the early-February meeting. The Australian dollar surged to a 15-month peak. “With the labour market resilient as ever … there is a growing imperative for the RBA to tighten policy settings,” noted Abhijit Surya, senior APAC economist at Capital Economics. 6

This context plays a key role in ANZ’s earnings, even before factoring in the Suncorp buzz. Rising rates boost the net interest margin — the difference between what banks earn on loans versus what they pay on deposits — but they may also dampen credit demand and increase the risk of bad debts.

Yet the Suncorp dispute stands apart. Political resistance to job cuts and branch closures might stall restructuring plans, making another headline-grabbing episode quite likely.

Coming up, the ABS consumer price index for December 2025 is set for release on Jan. 28 at 11:30 a.m. AEDT. Then, the Reserve Bank of Australia’s Monetary Policy Board meets Feb. 2–3. The ASX will be closed Monday for Australia Day, cutting the trading week short as investors eye both the CPI data and ongoing concerns around Suncorp job cuts. 7

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Macquarie shares jump on jobs shock and buyback extension — what to watch before the RBA meeting
Previous Story

Macquarie shares jump on jobs shock and buyback extension — what to watch before the RBA meeting

Why Paladin Energy’s share price hit a fresh high — and what ASX:PDN investors watch next
Next Story

Why Paladin Energy’s share price hit a fresh high — and what ASX:PDN investors watch next

Go toTop